Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac stem cell-based therapy.
Sirish P, Thai PN, Lee JH, Yang J, Zhang XD, Ren L, Li N, Timofeyev V, Lee KSS, Nader CE, Rowland DJ, Yechikov S, Ganaga S, Young N, Lieu DK, Yamoah EN, Hammock BD, Chiamvimonvat N.
Sirish P, et al. Among authors: li n.
Stem Cells Transl Med. 2020 Dec;9(12):1570-1584. doi: 10.1002/sctm.20-0143. Epub 2020 Aug 13.
Stem Cells Transl Med. 2020.
PMID: 32790136
Free PMC article.